Aura Biosciences Target Price

Analysts' average 12-month price target for Aura Biosciences is $17.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.15

Average Target Price

$17.00

137.8% upside

1 analysts in the last 4 months

High: $17 | Low: $17

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-12	Leerink Partners	$17	137.8% upside
2025-03-26	JMP SecuritiesJonathan Wolleben	$19	165.7% upside
2025-03-25	H.C. WainwrightEdward White	$25	249.7% upside
2024-10-18	ScotiabankGeorge Farmer	$23	221.7% upside
2024-10-18	H.C. WainwrightEd White II	$22	207.7% upside
2024-10-18	BTIGJulian Harrison	$24	235.7% upside
2024-07-25	H.C. WainwrightEdward White	$21	193.7% upside
2022-11-11	JMP Securities	$30	319.6% upside

Aura Biosciences (AURA) FAQ

Aura Biosciences (AURA) currently reports a target price of $17. Use the charts on this page to explore Aura Biosciences's target price history and peer comparisons.

Analysts' average 12-month price target for Aura Biosciences is $17, about 137.8% upside from the current share price of $7.15. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $17, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aura Biosciences, and consider following AURA for alerts when major investors trade the stock.